Onychomadesis in a COVID-19 patient

We report the case of a 67-year-old woman who developed onychomadesis on 9 of her fingers 2 months after recovering from COVID-19, with subsequent full nail regrowth after 4 months. The development of onychomadesis in COVID-19 is probably related to inhibition of nail proliferation due to fever, dir...

Descripción completa

Detalles Bibliográficos
Autores principales: Ivanova, Zlatina Georgieva, Aleksiev, Teodor Ivanov, Dobrev, Hristo Petrov
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703413/
https://www.ncbi.nlm.nih.gov/pubmed/36441360
http://dx.doi.org/10.1007/s10354-022-00988-1
_version_ 1784839841743110144
author Ivanova, Zlatina Georgieva
Aleksiev, Teodor Ivanov
Dobrev, Hristo Petrov
author_facet Ivanova, Zlatina Georgieva
Aleksiev, Teodor Ivanov
Dobrev, Hristo Petrov
author_sort Ivanova, Zlatina Georgieva
collection PubMed
description We report the case of a 67-year-old woman who developed onychomadesis on 9 of her fingers 2 months after recovering from COVID-19, with subsequent full nail regrowth after 4 months. The development of onychomadesis in COVID-19 is probably related to inhibition of nail proliferation due to fever, direct viral damage, or an inflammatory process associated with endothelial damage and obliterative microangiopathy in the nail matrix area. Clinicians should be aware of nail changes and actively seek them out in patients with COVID-19.
format Online
Article
Text
id pubmed-9703413
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-97034132022-11-28 Onychomadesis in a COVID-19 patient Ivanova, Zlatina Georgieva Aleksiev, Teodor Ivanov Dobrev, Hristo Petrov Wien Med Wochenschr Case Report We report the case of a 67-year-old woman who developed onychomadesis on 9 of her fingers 2 months after recovering from COVID-19, with subsequent full nail regrowth after 4 months. The development of onychomadesis in COVID-19 is probably related to inhibition of nail proliferation due to fever, direct viral damage, or an inflammatory process associated with endothelial damage and obliterative microangiopathy in the nail matrix area. Clinicians should be aware of nail changes and actively seek them out in patients with COVID-19. Springer Vienna 2022-11-28 /pmc/articles/PMC9703413/ /pubmed/36441360 http://dx.doi.org/10.1007/s10354-022-00988-1 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, ein Teil von Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Case Report
Ivanova, Zlatina Georgieva
Aleksiev, Teodor Ivanov
Dobrev, Hristo Petrov
Onychomadesis in a COVID-19 patient
title Onychomadesis in a COVID-19 patient
title_full Onychomadesis in a COVID-19 patient
title_fullStr Onychomadesis in a COVID-19 patient
title_full_unstemmed Onychomadesis in a COVID-19 patient
title_short Onychomadesis in a COVID-19 patient
title_sort onychomadesis in a covid-19 patient
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703413/
https://www.ncbi.nlm.nih.gov/pubmed/36441360
http://dx.doi.org/10.1007/s10354-022-00988-1
work_keys_str_mv AT ivanovazlatinageorgieva onychomadesisinacovid19patient
AT aleksievteodorivanov onychomadesisinacovid19patient
AT dobrevhristopetrov onychomadesisinacovid19patient

Ejemplares similares